首页 > 最新文献

Biomedicine / [publiee pour l'A.A.I.C.I.G.]最新文献

英文 中文
Lymphocyte nuclear refringence in two inbred strains of rat. Modifications of NRT during adjuvant arthritis. 两种大鼠近交系淋巴细胞核折射。佐剂性关节炎期间NRT的改变。
A Kahan, A Pompidou, P Michel, D Esnous, F Delbarre

Nuclear refringence test (NRT) was studied in two inbred strains of rats: Lewis (LEW) and Wistar AG (WAG), the first develops a severe arthritis while the later only slight inflammation. Before adjuvant injection, a good NRT to ConA, PHA and Isoprinosine was observed in LEW but a poor one in WAG. After adjuvant injection a striking difference appears between the two strains concerning ConA response: in LEW the response is significantly lower on day 14, while in WAG the initial poor response is not modified. These data suggest that in WAG the suppressor T lymphocytes are already activated in vivo and are no longer responsive in vitro. The responses to PHA and Isoprinosine are parallel in both strains, the NRT response diminishes on day 14 in LEW and on day 21 in WAG.

对Lewis (LEW)和Wistar AG (WAG)两种近交系大鼠进行了核折射试验(NRT),前者表现为严重的关节炎,后者仅表现为轻微的炎症。佐剂注射前,LEW对ConA、PHA和异丙氨酸的NRT良好,而WAG的NRT较差。注射佐剂后,两株在ConA反应方面出现了显著差异:LEW在第14天的反应明显降低,而WAG最初的不良反应没有得到改善。这些数据表明,在WAG中,抑制T淋巴细胞在体内已经被激活,并且在体外不再有反应。两种菌株对PHA和异丙氨酸的反应是平行的,LEW的NRT反应在第14天减弱,WAG在第21天减弱。
{"title":"Lymphocyte nuclear refringence in two inbred strains of rat. Modifications of NRT during adjuvant arthritis.","authors":"A Kahan,&nbsp;A Pompidou,&nbsp;P Michel,&nbsp;D Esnous,&nbsp;F Delbarre","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Nuclear refringence test (NRT) was studied in two inbred strains of rats: Lewis (LEW) and Wistar AG (WAG), the first develops a severe arthritis while the later only slight inflammation. Before adjuvant injection, a good NRT to ConA, PHA and Isoprinosine was observed in LEW but a poor one in WAG. After adjuvant injection a striking difference appears between the two strains concerning ConA response: in LEW the response is significantly lower on day 14, while in WAG the initial poor response is not modified. These data suggest that in WAG the suppressor T lymphocytes are already activated in vivo and are no longer responsive in vitro. The responses to PHA and Isoprinosine are parallel in both strains, the NRT response diminishes on day 14 in LEW and on day 21 in WAG.</p>","PeriodicalId":9217,"journal":{"name":"Biomedicine / [publiee pour l'A.A.I.C.I.G.]","volume":"35 7-8","pages":"212-4"},"PeriodicalIF":0.0,"publicationDate":"1981-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18030073","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tube LAI assay in diagnosis and monitoring of a cancer disease. 试管LAI测定在肿瘤疾病诊断和监测中的应用。
M Hasek, V Holán, M Kousalová

The tube leukocyte adherence inhibition (LAI) assay was used to follow the specific antitumor immunity in patients with tumors of the urogenital tract, carcinomas of the larynx, melanomas and lung tumors. Positive reactivity was observed in more than 80% of the patients with tumor, whereas less than 5% of the controls were positive. The results show that the tube LAI assay holds promise for diagnosing and monitoring cancer diseases.

采用白细胞粘附抑制(LAI)法观察泌尿生殖道肿瘤、喉癌、黑色素瘤和肺癌患者的特异性抗肿瘤免疫反应。在80%以上的肿瘤患者中观察到阳性反应,而对照组的阳性反应不到5%。结果表明,试管LAI测定在诊断和监测癌症疾病方面具有前景。
{"title":"Tube LAI assay in diagnosis and monitoring of a cancer disease.","authors":"M Hasek,&nbsp;V Holán,&nbsp;M Kousalová","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The tube leukocyte adherence inhibition (LAI) assay was used to follow the specific antitumor immunity in patients with tumors of the urogenital tract, carcinomas of the larynx, melanomas and lung tumors. Positive reactivity was observed in more than 80% of the patients with tumor, whereas less than 5% of the controls were positive. The results show that the tube LAI assay holds promise for diagnosing and monitoring cancer diseases.</p>","PeriodicalId":9217,"journal":{"name":"Biomedicine / [publiee pour l'A.A.I.C.I.G.]","volume":"35 7-8","pages":"207-8"},"PeriodicalIF":0.0,"publicationDate":"1981-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18096604","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pseudohypoglycemia in a patient with leukemia. 白血病患者的假性低血糖。
B Canivet, P Elbaze, P Dujardin, P Freychet
{"title":"Pseudohypoglycemia in a patient with leukemia.","authors":"B Canivet,&nbsp;P Elbaze,&nbsp;P Dujardin,&nbsp;P Freychet","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":9217,"journal":{"name":"Biomedicine / [publiee pour l'A.A.I.C.I.G.]","volume":"35 7-8","pages":"203-4"},"PeriodicalIF":0.0,"publicationDate":"1981-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18355351","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Localisation of alphafetoprotein (AFP) in murine teratocarcinoma. 甲胎蛋白(AFP)在小鼠畸胎瘤中的定位。
J Trojan, J Uriel

Solid tumours with histopathological characteristics of teratocarcinoma (generally presenting the structures of nervous origin) were induced in the mouse by subcutaneous inoculation with murine embryonal carcinoma (EC) cells of line PCC4-azal. An indirect immunoperoxidase technique using anti-mouse AFP antibodies was applied for the localization of the protein on paraffin sections of tissue fixed with acetic acid-ethanol. The PCC4-azal EC cells were AFP negative in vitro. In the solid tumours, the immature embryonal or fetal components (i. e. tubes or cysts mimicking the development of the neural tube) and the groups of neuroepithelial cells arranged in more or less differentiating structures (pseudotubes, cluters) were AFP positive; on the contrary, cells of the same differentiated neuroepithelial type, but lacking recognizable tissue architecture, were AFP negative. Mature, adult components were AFP negative. Undifferentiated cancer components, whether structured or not, were AFP negative. These results suggest that the intracellular presence of AFP requires a minimum degree of both cell differentiation and tissue organization.

用PCC4-azal系小鼠胚胎癌(EC)细胞皮下接种,在小鼠体内诱导了具有畸胎癌组织病理学特征的实体瘤(一般呈现神经源性结构)。采用抗小鼠AFP抗体间接免疫过氧化物酶技术在醋酸-乙醇固定组织石蜡切片上定位该蛋白。PCC4-azal EC细胞体外AFP阴性。在实体瘤中,未成熟的胚胎或胎儿成分(即模仿神经管发育的管或囊肿)和排列成或多或少分化结构的神经上皮细胞群(假管,簇状细胞)呈AFP阳性;相反,相同分化的神经上皮类型的细胞,但缺乏可识别的组织结构,AFP阴性。成熟、成体成分为AFP阴性。未分化的癌症成分,无论是否结构化,均为AFP阴性。这些结果表明,细胞内AFP的存在需要最低程度的细胞分化和组织组织。
{"title":"Localisation of alphafetoprotein (AFP) in murine teratocarcinoma.","authors":"J Trojan,&nbsp;J Uriel","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Solid tumours with histopathological characteristics of teratocarcinoma (generally presenting the structures of nervous origin) were induced in the mouse by subcutaneous inoculation with murine embryonal carcinoma (EC) cells of line PCC4-azal. An indirect immunoperoxidase technique using anti-mouse AFP antibodies was applied for the localization of the protein on paraffin sections of tissue fixed with acetic acid-ethanol. The PCC4-azal EC cells were AFP negative in vitro. In the solid tumours, the immature embryonal or fetal components (i. e. tubes or cysts mimicking the development of the neural tube) and the groups of neuroepithelial cells arranged in more or less differentiating structures (pseudotubes, cluters) were AFP positive; on the contrary, cells of the same differentiated neuroepithelial type, but lacking recognizable tissue architecture, were AFP negative. Mature, adult components were AFP negative. Undifferentiated cancer components, whether structured or not, were AFP negative. These results suggest that the intracellular presence of AFP requires a minimum degree of both cell differentiation and tissue organization.</p>","PeriodicalId":9217,"journal":{"name":"Biomedicine / [publiee pour l'A.A.I.C.I.G.]","volume":"34 3","pages":"140-6"},"PeriodicalIF":0.0,"publicationDate":"1981-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"17239920","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Interaction between heparin and adriamycin in mice bearing the Lewis lung carcinoma. 肝素与阿霉素在Lewis肺癌小鼠中的相互作用。
T Colombo, F Delaini, R Ferrari, M B Donati, M G Donelli, A Poggi

The investigation was prompted by the observation that adriamycin can interact with heparin in vitro and reduces its anticoagulant activity in ex vivo tests in humans. The possible interactions between these two drugs were studied in C57Bl/6J mice bearing the Lewis Lung Carcinoma (3LL). The anticoagulant activity of heparin was temporarily reduced by concomitant treatment with adriamycin, as indicated by both activated partial thromboplastin times and blood recalcification times. In contrast, no changes were found in the kinetics of adriamycin disappearance from blood and accumulation in tissues if mice had been pretreated with heparin. Moreover, the effect of adriamycin on tumour and metastasis growth was unchanged by the association with the anticoagulant. These data indicate that the short-lived interaction between adriamycin and heparin, which can be documented by coagulation tests, does not necessarily involve a modification in the anticancer activity of the anthracycline.

这项研究是由于观察到阿霉素在体外可以与肝素相互作用,并在人体内试验中降低其抗凝血活性。在Lewis肺癌(3LL) C57Bl/6J小鼠中研究了这两种药物之间可能的相互作用。肝素的抗凝活性在阿霉素的联合治疗下暂时降低,这是由激活的部分凝血活酶时间和血液再钙化时间所显示的。相比之下,如果用肝素预处理小鼠,阿霉素从血液中消失和在组织中积累的动力学没有变化。此外,阿霉素对肿瘤和转移生长的影响与抗凝剂的关联没有变化。这些数据表明,阿霉素和肝素之间的短暂相互作用,可以通过凝血试验证明,并不一定涉及蒽环类药物抗癌活性的改变。
{"title":"Interaction between heparin and adriamycin in mice bearing the Lewis lung carcinoma.","authors":"T Colombo,&nbsp;F Delaini,&nbsp;R Ferrari,&nbsp;M B Donati,&nbsp;M G Donelli,&nbsp;A Poggi","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The investigation was prompted by the observation that adriamycin can interact with heparin in vitro and reduces its anticoagulant activity in ex vivo tests in humans. The possible interactions between these two drugs were studied in C57Bl/6J mice bearing the Lewis Lung Carcinoma (3LL). The anticoagulant activity of heparin was temporarily reduced by concomitant treatment with adriamycin, as indicated by both activated partial thromboplastin times and blood recalcification times. In contrast, no changes were found in the kinetics of adriamycin disappearance from blood and accumulation in tissues if mice had been pretreated with heparin. Moreover, the effect of adriamycin on tumour and metastasis growth was unchanged by the association with the anticoagulant. These data indicate that the short-lived interaction between adriamycin and heparin, which can be documented by coagulation tests, does not necessarily involve a modification in the anticancer activity of the anthracycline.</p>","PeriodicalId":9217,"journal":{"name":"Biomedicine / [publiee pour l'A.A.I.C.I.G.]","volume":"34 3","pages":"124-8"},"PeriodicalIF":0.0,"publicationDate":"1981-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18350873","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of salbutamol, a putative cerebral beta agonist on sleep stages and interictal epileptic discharges. 脑β受体激动剂沙丁胺醇对睡眠阶段和癫痫发作间期放电的影响。
F Laffont, A Autret, E DEgiovanni, B Lucas

The effects of Salbutamol 1.5 mg in 250 ml dextrose solution was tested on 14 epileptic patients following a double blind cross-over design. Sleep parameters and interictal paroxysmal activities density were measured. No seizures were encountered during the experiment. No modification of either sleep parameters (duration of sleep stages, latency of sleep and paradoxical sleep, duration of sleep cycles and awaking) or density of P. A. during waking state, on stage I, II, III and IV and paradoxical sleep were observed. In other respects, 5 patients had no P. A. during polygraphic sessions. They exhibited a longer duration of paradoxical sleep and a shorter duration of awaking than the 9 other patients with P. A. So with the dosage used here no implication of central beta-adrenoceptors in sleep mechanisms and production of epileptic activity are suggested.

采用双盲交叉试验设计,研究了沙丁胺醇1.5 mg加入250 ml葡萄糖溶液对14例癫痫患者的影响。测量睡眠参数和间歇发作活动密度。实验过程中未发生癫痫发作。睡眠参数(睡眠阶段的持续时间、睡眠和矛盾睡眠的潜伏期、睡眠周期和觉醒的持续时间)或醒着状态、I、II、III和IV阶段和矛盾睡眠期间的p.a.密度均未观察到改变。其他方面,5例患者在测谎期间没有p.a.。与其他9例p.a.患者相比,他们表现出更长的矛盾睡眠时间和更短的清醒时间。因此,在这里使用的剂量下,中枢-肾上腺素受体在睡眠机制和癫痫活动的产生中没有暗示。
{"title":"Effect of salbutamol, a putative cerebral beta agonist on sleep stages and interictal epileptic discharges.","authors":"F Laffont,&nbsp;A Autret,&nbsp;E DEgiovanni,&nbsp;B Lucas","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The effects of Salbutamol 1.5 mg in 250 ml dextrose solution was tested on 14 epileptic patients following a double blind cross-over design. Sleep parameters and interictal paroxysmal activities density were measured. No seizures were encountered during the experiment. No modification of either sleep parameters (duration of sleep stages, latency of sleep and paradoxical sleep, duration of sleep cycles and awaking) or density of P. A. during waking state, on stage I, II, III and IV and paradoxical sleep were observed. In other respects, 5 patients had no P. A. during polygraphic sessions. They exhibited a longer duration of paradoxical sleep and a shorter duration of awaking than the 9 other patients with P. A. So with the dosage used here no implication of central beta-adrenoceptors in sleep mechanisms and production of epileptic activity are suggested.</p>","PeriodicalId":9217,"journal":{"name":"Biomedicine / [publiee pour l'A.A.I.C.I.G.]","volume":"35 7-8","pages":"220-3"},"PeriodicalIF":0.0,"publicationDate":"1981-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18355354","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical chronopharmacology. 临床chronopharmacology。
A Reinberg, M Smolensky, F Lévi

Circadian (approximately or equal to 24 h), circannual (approximately or equal to 1 year) and other biological rhythms of endogenous origin, detectable at all levels of organization, constitute a temporal structure in all animal species, including man. Circadian, circannual and other rhythmic changes in biological susceptibility and response of organisms to a large variety of physical as well as chemical agents including medications and foods are rather common phenomena. Modern chronopharmacology investigates drug effects: a) as a function of biological timing and b) upon parameters characterising the endogenous bioperiodicities. A better understanding of periodic and thus predictable changes in drug effects can be attained through consideration of three complementary concepts: the chronokinetics of a drug (rhythmic changes in its pharmacokinetics): the chronesthesy (rhythmic changes in susceptibility of target biosystem to this drug), and the chronergy (the drug-integrated overall effects). One of the aims of chronopharmacology is solving problems of drug optimization. Knowledge of those administration times coinciding with best effectiveness or tolerance is required to optimize both timing(s) and dosage(s) of a medication. Illustrative examples of both experimental and clinical investigative chronopharmacology are corticosteroids and anticancerous agents.

昼夜节律(大约或等于24小时)、年轮节律(大约或等于1年)和其他内源性生物节律,在所有组织水平上都可以检测到,构成了包括人类在内的所有动物物种的时间结构。生物对包括药物和食物在内的各种物理和化学试剂的生物敏感性和反应的昼夜、周期和其他节律变化是相当普遍的现象。现代时间药理学研究药物效应:a)作为生物时间的函数和b)内源性生物周期特征参数。通过考虑三个互补的概念,可以更好地理解药物作用的周期性和可预测的变化:药物的时间动力学(药代动力学的节律性变化)、时间感(靶生物系统对该药物的敏感性的节律性变化)和时间能(药物综合总体效应)。时间药理学的目标之一是解决药物优化问题。了解那些符合最佳疗效或耐受性的给药时间是优化药物的时间和剂量所必需的。实验和临床研究时间药理学的典型例子是皮质类固醇和抗癌药物。
{"title":"Clinical chronopharmacology.","authors":"A Reinberg,&nbsp;M Smolensky,&nbsp;F Lévi","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Circadian (approximately or equal to 24 h), circannual (approximately or equal to 1 year) and other biological rhythms of endogenous origin, detectable at all levels of organization, constitute a temporal structure in all animal species, including man. Circadian, circannual and other rhythmic changes in biological susceptibility and response of organisms to a large variety of physical as well as chemical agents including medications and foods are rather common phenomena. Modern chronopharmacology investigates drug effects: a) as a function of biological timing and b) upon parameters characterising the endogenous bioperiodicities. A better understanding of periodic and thus predictable changes in drug effects can be attained through consideration of three complementary concepts: the chronokinetics of a drug (rhythmic changes in its pharmacokinetics): the chronesthesy (rhythmic changes in susceptibility of target biosystem to this drug), and the chronergy (the drug-integrated overall effects). One of the aims of chronopharmacology is solving problems of drug optimization. Knowledge of those administration times coinciding with best effectiveness or tolerance is required to optimize both timing(s) and dosage(s) of a medication. Illustrative examples of both experimental and clinical investigative chronopharmacology are corticosteroids and anticancerous agents.</p>","PeriodicalId":9217,"journal":{"name":"Biomedicine / [publiee pour l'A.A.I.C.I.G.]","volume":"34 4","pages":"171-8"},"PeriodicalIF":0.0,"publicationDate":"1981-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18215479","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Decreased phagocytosis and antibody-dependent cellular cytotoxicity (ADCC) in type-1 diabetes. 1型糖尿病患者吞噬功能和抗体依赖性细胞毒性(ADCC)降低。
A Sabioncello, S Rabatic, M Kadrnka-Lovrencic, V Oberiter, D Dekaris

Leucocyte-mediated phagocytosis and antibody-dependent cellular cytotoxicity (ADCC) were tested in 48 children with type-1 diabetes and in 22 healthy children. Both phagocytosis and ADCC for opsonized 51Cr-erythrocytes significantly decreased in the diabetics. Phagocytosis decreased in well and in poorly balanced diabetics, but the latter, having type-1 diabetes for less than 5 years, exhibited a lower phagocytic capacity than the patients with a longer duration of disease. The decrease of ADCC in poorly balanced patients was greater than in the well balanced ones as compared to the controls. The duration of diabetes was without influence on their leucocytes' ADCC.

在48例1型糖尿病儿童和22例健康儿童中检测了白细胞介导的吞噬和抗体依赖性细胞毒性(ADCC)。糖尿病患者51cr -红细胞的吞噬和ADCC均显著降低。在平衡良好和平衡不良的糖尿病患者中,吞噬能力下降,但后者,患有1型糖尿病少于5年,表现出较低的吞噬能力,比病程较长的患者。与对照组相比,平衡不良的患者ADCC的下降幅度大于平衡良好的患者。糖尿病病程对白细胞ADCC无影响。
{"title":"Decreased phagocytosis and antibody-dependent cellular cytotoxicity (ADCC) in type-1 diabetes.","authors":"A Sabioncello,&nbsp;S Rabatic,&nbsp;M Kadrnka-Lovrencic,&nbsp;V Oberiter,&nbsp;D Dekaris","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Leucocyte-mediated phagocytosis and antibody-dependent cellular cytotoxicity (ADCC) were tested in 48 children with type-1 diabetes and in 22 healthy children. Both phagocytosis and ADCC for opsonized 51Cr-erythrocytes significantly decreased in the diabetics. Phagocytosis decreased in well and in poorly balanced diabetics, but the latter, having type-1 diabetes for less than 5 years, exhibited a lower phagocytic capacity than the patients with a longer duration of disease. The decrease of ADCC in poorly balanced patients was greater than in the well balanced ones as compared to the controls. The duration of diabetes was without influence on their leucocytes' ADCC.</p>","PeriodicalId":9217,"journal":{"name":"Biomedicine / [publiee pour l'A.A.I.C.I.G.]","volume":"35 7-8","pages":"227-9"},"PeriodicalIF":0.0,"publicationDate":"1981-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18359959","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Aging of the erythrocyte XIII. Decrease in nitroxide reducing capacity. 红细胞的老化氮氧化物还原能力下降。
G Bartosz, K Gwozdzinski, J Wagner

A method is proposed for the determination of nitroxide-reducing capacity (NRC) of erythrocytes, and other cells, based on measurements of reduction of a nitroxide stable free radical in cell suspensions by ESR spectroscopy. Comparison of different age fractions of bovine erythrocytes by this method demonstrates a decrease in NRC during cell aging in vivo.

本文提出了一种基于ESR光谱法测定细胞悬浮液中氮氧稳定自由基还原量的方法,用于测定红细胞和其他细胞的氮氧还原能力。用这种方法比较不同年龄的牛红细胞,表明NRC在细胞衰老过程中降低。
{"title":"Aging of the erythrocyte XIII. Decrease in nitroxide reducing capacity.","authors":"G Bartosz,&nbsp;K Gwozdzinski,&nbsp;J Wagner","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>A method is proposed for the determination of nitroxide-reducing capacity (NRC) of erythrocytes, and other cells, based on measurements of reduction of a nitroxide stable free radical in cell suspensions by ESR spectroscopy. Comparison of different age fractions of bovine erythrocytes by this method demonstrates a decrease in NRC during cell aging in vivo.</p>","PeriodicalId":9217,"journal":{"name":"Biomedicine / [publiee pour l'A.A.I.C.I.G.]","volume":"35 6","pages":"185-7"},"PeriodicalIF":0.0,"publicationDate":"1981-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"17341860","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The respective advantages of complement fixation and ELISA for routine diagnosis of cytomegalovirus infection. 补体固定与ELISA在巨细胞病毒感染常规诊断中的各自优势。
B Pozzetto, O G Gaudin

The results of CF and ELISA tests for cytomegalovirus performed on 270 sera of hospitalized patients show a positive correlation. As a general rule, ELISA is more sensitive than CF, except for a few sera collected from patients with immunological disorders. When two sequential sera are available, the CF remains a reliable and inexpensive method. But when only one serum can be obtained, the probability of an active CMV infection can be estimated on the IgM/IgG ratio. In 26% of the patients, this ratio was greater than or equal to 1. The ELISA is twice as expensive as the CF test. To reduce its cost, a simple method for preparing ELISA antigen from commercially-obtained CF antigens is described.

270例住院患者血清巨细胞病毒CF和ELISA检测结果呈正相关。一般来说,ELISA比CF更敏感,但少数免疫系统疾病患者的血清除外。当两种连续血清可用时,CF仍然是一种可靠且廉价的方法。但当只能获得一种血清时,可通过IgM/IgG比值估计CMV感染活动性的概率。在26%的患者中,该比值大于或等于1。ELISA的价格是CF检测的两倍。为了降低成本,本文描述了一种从市售CF抗原制备ELISA抗原的简单方法。
{"title":"The respective advantages of complement fixation and ELISA for routine diagnosis of cytomegalovirus infection.","authors":"B Pozzetto,&nbsp;O G Gaudin","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The results of CF and ELISA tests for cytomegalovirus performed on 270 sera of hospitalized patients show a positive correlation. As a general rule, ELISA is more sensitive than CF, except for a few sera collected from patients with immunological disorders. When two sequential sera are available, the CF remains a reliable and inexpensive method. But when only one serum can be obtained, the probability of an active CMV infection can be estimated on the IgM/IgG ratio. In 26% of the patients, this ratio was greater than or equal to 1. The ELISA is twice as expensive as the CF test. To reduce its cost, a simple method for preparing ELISA antigen from commercially-obtained CF antigens is described.</p>","PeriodicalId":9217,"journal":{"name":"Biomedicine / [publiee pour l'A.A.I.C.I.G.]","volume":"35 6","pages":"187-90"},"PeriodicalIF":0.0,"publicationDate":"1981-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"17341861","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Biomedicine / [publiee pour l'A.A.I.C.I.G.]
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1